Table I.

Demographics of the enrolled controls and patients. Results are given as mean ± SD

Groups	Age	Sex- ratio ♀/♂	Frequency HSV-1 infections	SCORAD	Total IgE	HSV IgG titer
NA (n=33)	30.4 ± 10.6	21/12	-	-	-	1:5,929 ± 9,794
NA/HSV (n=22)	32.1 ± 13	13/9	2.3 ± 1.3	-	-	1:16,959 ± 11,607
AD (n=34)	29.5 ± 8.7	20/14	-	34.6 ± 9.7	1,607 ± 3,244	1:7,644 ± 11,918
AD/HSV (n=37)	34.3 ± 11.4	21/16	2,4 ± 1.6	31.2 ± 11	1,627 ± 3,528	1:17,860 ± 8,345
AD/HSV/ EH history (n=19)	35.3 ± 9.9	4/15	1.7 ± 2.5	39.3 ± 11	4,391 ± 6,667	14,457 ± 11,743
AD/HSV/EH acute (n=14)	29.2 ± 8.2	4/10	1.6 ± 2.9	47.2 ± 12.2	6,245 ± 9,022	14,392 ± 13,708